Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Li, Chunyang
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease	Recruiting	4	1312	RoW	GV-971, Placebo	Green Valley (Shanghai) Pharmaceuticals Co., Ltd.	Alzheimer's Disease	06/29	12/29
NCT06544577: Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC	Recruiting	N/A	350	RoW	ELacestrant	SciClone Pharmaceuticals	ESR1 Gene Mutation, Advanced Breast Cancer, Safety	08/25	08/26
NCT06548919: Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer	Recruiting	N/A	450	RoW	Endocrine therapy, Chemotherapy Prednisone	SciClone Pharmaceuticals	ESR1 Gene Mutation, Advanced Breast Cancer	12/26	12/27